We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 02, 2020

Prognosis of Patients With Stage III Melanoma According to AJCCv8: A Reassessment

Journal of Clinical Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts
J. Clin. Oncol 2020 Jun 12;[EPub Ahead of Print], C Garbe, U Keim, S Suciu, T Amaral, TK Eigentler, A Gesierich, A Hauschild, L Heinzerling, F Kiecker, D Schadendorf, R Stadler, C Sunderkötter, T Tüting, J Utikal, U Wollina, CC Zouboulis, U Keilholz, A Testori, P Martus, U Leiter, AMM Eggermont

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading